This project develops an AI and robotic driven, decentralised pharmaceutical EU manufacturing platform to enhance crisis preparedness.
To address medicine shortages and supply chain disruptions, this project introduces an agile manufacturing platform for pharmacies and hospital pharmacies. Using 3D-inspired robotic dosing, AI-driven analytics, RFID tracking, and workflow automation, the system ensures real-time, scalable, and regulatory-compliant production of essential medicines. By decentralising pharmaceutical manufacturing, it enables rapid responses to crises, reduces bottlenecks and waste, and enhances EU healthcare resilience.
Explore EU innovative projects awarded the STEP Seal. View projects’ details, funding status, and connect with promoters via the interactive dashboard.
Other STEP stories on biotech
In Warsaw, STEP is supporting a pioneering gene therapy for Parkinson’s disease, helping strengthen Europe’s leadership in biotechnology and advanced medical research.
What if diagnosis could be faster, more precise and tailored to each patient? O-MAI is combining AI, imaging and omics sciences to help shape the future of personalised medicine in Europe
PharmSD 3.0 will develop an integrated, continuous-pharmaceutical spray drying process to enhance efficiency, scalability, and cost-effectiveness.
Discover STEP
Read more about STEP and its results
Learn about the Strategic Technologies for Europe Platform (STEP): its mission to boost EU investment in critical technologies, its scope and its synergies with 11 EU funding programmes. Driving innovation and competitiveness across Europe.
Discover innovative projects in digital, clean, bio and defence technology sectors and explore how they shape the future of innovation in Europe.
Funding allocations, STEP Seal projects, and sectoral investment trends in digital, clean-tech, and biotech. See how EU investments drive innovation and strategic autonomy.